IE52535B1
(en)
*
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
FR2537980B1
(fr)
*
|
1982-12-17 |
1986-12-19 |
Sandoz Sa |
Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
|
AU567155B2
(en)
*
|
1983-04-15 |
1987-11-12 |
Damon Biotech Inc. |
Capsules for releasing core material at constant rate
|
US4652443A
(en)
*
|
1983-06-07 |
1987-03-24 |
Japan Atomic Energy Research Institute |
Slow-release composite and process for producing the same
|
CH661206A5
(fr)
*
|
1983-09-23 |
1987-07-15 |
Debiopharm Sa |
Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
|
JPS60100516A
(ja)
*
|
1983-11-04 |
1985-06-04 |
Takeda Chem Ind Ltd |
徐放型マイクロカプセルの製造法
|
US5693343A
(en)
|
1984-03-16 |
1997-12-02 |
The United States Of America As Represented By The Secretary Of The Army |
Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
|
US6309669B1
(en)
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
US6410056B1
(en)
|
1984-03-16 |
2002-06-25 |
The United States Of America As Represented By The Secretary Of The Army |
Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
|
CN100391445C
(zh)
*
|
1996-01-24 |
2008-06-04 |
美国政府陆军部 |
新型的“非突发的”持续释放聚(丙交酯/乙交酯)的微球
|
USRE40786E1
(en)
|
1984-03-16 |
2009-06-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
|
US6217911B1
(en)
|
1995-05-22 |
2001-04-17 |
The United States Of America As Represented By The Secretary Of The Army |
sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
|
DE3428372A1
(de)
*
|
1984-08-01 |
1986-02-13 |
Hoechst Ag, 6230 Frankfurt |
Mikrokapseln von regulatorischen peptiden mit kontrollierter freisetzung, verfahren zu ihrer herstellung und injektionszubereitungen
|
CH660302A5
(fr)
*
|
1984-10-17 |
1987-04-15 |
Debiopharm Sa |
Procede de micro-encapsulation en phase heterogene de substances medicamenteuses hydrosolubles.
|
JP2551756B2
(ja)
*
|
1985-05-07 |
1996-11-06 |
武田薬品工業株式会社 |
ポリオキシカルボン酸エステルおよびその製造法
|
US4666704A
(en)
*
|
1985-05-24 |
1987-05-19 |
International Minerals & Chemical Corp. |
Controlled release delivery system for macromolecules
|
US5137874A
(en)
*
|
1985-07-29 |
1992-08-11 |
American Cyanamid Co. |
Partially coated C10 -C20 fatty acid salts of peptides having molecular weights up to about 5,000
|
US5059422A
(en)
*
|
1985-07-29 |
1991-10-22 |
American Cyanamid Company |
Continuous release phenylethanolamine derivative compositions
|
US5169633A
(en)
*
|
1985-07-29 |
1992-12-08 |
American Cyanamid Company |
Continuous release phenylethanolamine derivative compositions
|
CH669506A5
(en)
*
|
1986-01-13 |
1989-03-31 |
Hugo Degen |
Oscillating and reclining furniture
|
US4959217A
(en)
*
|
1986-05-22 |
1990-09-25 |
Syntex (U.S.A.) Inc. |
Delayed/sustained release of macromolecules
|
US4962091A
(en)
*
|
1986-05-23 |
1990-10-09 |
Syntex (U.S.A.) Inc. |
Controlled release of macromolecular polypeptides
|
JP2526589B2
(ja)
*
|
1986-08-08 |
1996-08-21 |
武田薬品工業株式会社 |
ペプチド含有マイクロカプセルおよびその製造法
|
US6024983A
(en)
*
|
1986-10-24 |
2000-02-15 |
Southern Research Institute |
Composition for delivering bioactive agents for immune response and its preparation
|
ES2102347T3
(es)
|
1987-02-20 |
1997-08-01 |
Genentech Inc |
Metodos y composiciones para la utilizacion de polipeptidos env y anticuerpos anti-env de hiv.
|
US5028430A
(en)
*
|
1987-05-08 |
1991-07-02 |
Syntex (U.S.A.) Inc. |
Delivery systems for the controlled administration of LHRH analogs
|
US5000886A
(en)
*
|
1987-05-26 |
1991-03-19 |
American Cyanamid Company |
Silicone-hardened pharmaceutical microcapsules and process of making the same
|
US4897268A
(en)
*
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
US5212154A
(en)
*
|
1987-08-14 |
1993-05-18 |
Akzo N.V. |
Preparation for treating complications in diabetes
|
GB2209937B
(en)
*
|
1987-09-21 |
1991-07-03 |
Depiopharm S A |
Water insoluble polypeptides
|
AU2810189A
(en)
*
|
1987-10-30 |
1989-05-23 |
Stolle Research & Development Corporation |
Low residual solvent microspheres and microencapsulation process
|
DE3738228A1
(de)
*
|
1987-11-11 |
1989-05-24 |
Hoechst Ag |
Verfahren zur herstellung von bioabbaubaren mikrokapseln wasserloeslicher peptide und proteine sowie nach diesem verfahren erhaltene mikrokapseln
|
DE3744329A1
(de)
*
|
1987-12-28 |
1989-07-06 |
Schwarz Pharma Gmbh |
Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
|
US5271945A
(en)
*
|
1988-07-05 |
1993-12-21 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsule for water soluble drug
|
ZA905327B
(en)
*
|
1989-07-07 |
1992-03-25 |
Sandoz Ltd |
Sustained release formulations of water soluble peptides
|
US5538739A
(en)
*
|
1989-07-07 |
1996-07-23 |
Sandoz Ltd. |
Sustained release formulations of water soluble peptides
|
PH30995A
(en)
*
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
HU221294B1
(en)
*
|
1989-07-07 |
2002-09-28 |
Novartis Ag |
Process for producing retarde compositions containing the active ingredient in a polymeric carrier
|
US5225205A
(en)
*
|
1989-07-28 |
1993-07-06 |
Debiopharm S.A. |
Pharmaceutical composition in the form of microparticles
|
CH679207A5
(nl)
*
|
1989-07-28 |
1992-01-15 |
Debiopharm Sa |
|
US5439688A
(en)
*
|
1989-07-28 |
1995-08-08 |
Debio Recherche Pharmaceutique S.A. |
Process for preparing a pharmaceutical composition
|
US5084443A
(en)
*
|
1989-12-04 |
1992-01-28 |
Biomeasure, Inc. |
Promoting expression of acetylcholine receptors with lhrh antagonist
|
MY107937A
(en)
*
|
1990-02-13 |
1996-06-29 |
Takeda Chemical Industries Ltd |
Prolonged release microcapsules.
|
JP2653255B2
(ja)
|
1990-02-13 |
1997-09-17 |
武田薬品工業株式会社 |
長期徐放型マイクロカプセル
|
US6353030B1
(en)
|
1990-08-01 |
2002-03-05 |
Novartis Ag |
Relating to organic compounds
|
ZA918168B
(en)
*
|
1990-10-16 |
1993-04-14 |
Takeda Chemical Industries Ltd |
Prolonged release preparation and polymers thereof.
|
IT1243390B
(it)
*
|
1990-11-22 |
1994-06-10 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
|
DE4041563A1
(de)
*
|
1990-12-22 |
1992-06-25 |
Sanol Arznei Schwarz Gmbh |
Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
|
AU8303691A
(en)
|
1991-04-24 |
1992-12-21 |
United States Of America, As Represented By The Secretary Of The Army, The |
Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
CH683149A5
(fr)
*
|
1991-07-22 |
1994-01-31 |
Debio Rech Pharma Sa |
Procédé pour la préparation de microsphères en matériau polymère biodégradable.
|
AU674500B2
(en)
|
1991-11-04 |
1997-01-02 |
Genetics Institute, Llc |
Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
|
US6326458B1
(en)
|
1992-01-24 |
2001-12-04 |
Cargill, Inc. |
Continuous process for the manufacture of lactide and lactide polymers
|
US5258488A
(en)
*
|
1992-01-24 |
1993-11-02 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5247059A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for the manufacture of a purified lactide from esters of lactic acid
|
US5142023A
(en)
*
|
1992-01-24 |
1992-08-25 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US6005067A
(en)
|
1992-01-24 |
1999-12-21 |
Cargill Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5247058A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5656297A
(en)
*
|
1992-03-12 |
1997-08-12 |
Alkermes Controlled Therapeutics, Incorporated |
Modulated release from biocompatible polymers
|
GB9211268D0
(en)
*
|
1992-05-28 |
1992-07-15 |
Ici Plc |
Salts of basic peptides with carboxyterminated polyesters
|
DE4223169C1
(de)
|
1992-07-10 |
1993-11-25 |
Ferring Arzneimittel Gmbh |
Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe
|
JP2651320B2
(ja)
*
|
1992-07-16 |
1997-09-10 |
田辺製薬株式会社 |
徐放性マイクロスフェア製剤の製造方法
|
EP0595030A3
(en)
*
|
1992-10-01 |
1995-06-07 |
Tanabe Seiyaku Co |
Composition of microspheres with several delayed release nuclei and its preparation process.
|
ATE199944T1
(de)
*
|
1992-10-02 |
2001-04-15 |
Cargill Inc |
Schmelzstabiles lactidpolymergewebe und verfahren zu seiner herstellung
|
NZ256978A
(en)
*
|
1992-10-02 |
1996-05-28 |
Cargill Inc |
Paper product coated with a poly(lactide) composition comprising no more than 5 wt % lactide monomer, the poly(lactide) having a number average mw of 10,000 to 200,000
|
US6005068A
(en)
*
|
1992-10-02 |
1999-12-21 |
Cargill Incorporated |
Melt-stable amorphous lactide polymer film and process for manufacture thereof
|
US5338822A
(en)
*
|
1992-10-02 |
1994-08-16 |
Cargill, Incorporated |
Melt-stable lactide polymer composition and process for manufacture thereof
|
TW333456B
(en)
*
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
UA61046C2
(en)
|
1992-12-07 |
2003-11-17 |
Takeda Chemical Industries Ltd |
Sustained-release preparation and method for its manufacture
|
US6939546B2
(en)
|
1993-05-21 |
2005-09-06 |
The United States Of America As Represented By The Secretary Of The Army |
Model for testing immunogenicity of peptides
|
US6440457B1
(en)
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US6087324A
(en)
|
1993-06-24 |
2000-07-11 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
EP0723402B1
(en)
|
1993-08-30 |
2010-08-18 |
Baylor College Of Medicine |
Senescent cell-derived inhibitors of dna synthesis
|
SI0729357T1
(en)
*
|
1993-11-19 |
2005-06-30 |
Janssen Pharmaceutica N.V. |
Microencapsulated 1,2-benzazoles
|
FR2713933B1
(fr)
*
|
1993-12-16 |
1996-02-02 |
Rhone Merieux |
Méthode de superovulation des femelles bovines, méthode de mise en anoestrus et kit approprié.
|
US6855331B2
(en)
|
1994-05-16 |
2005-02-15 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US6447796B1
(en)
|
1994-05-16 |
2002-09-10 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US6117455A
(en)
|
1994-09-30 |
2000-09-12 |
Takeda Chemical Industries, Ltd. |
Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
US7033608B1
(en)
|
1995-05-22 |
2006-04-25 |
The United States Of America As Represented By The Secretary Of The Army |
“Burst-free” sustained release poly-(lactide/glycolide) microspheres
|
US5674888A
(en)
*
|
1995-06-07 |
1997-10-07 |
University Of California |
Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
|
US5599535A
(en)
*
|
1995-06-07 |
1997-02-04 |
Regents Of The University Of California |
Methods for the cyto-protection of the trabecular meshwork
|
US5877224A
(en)
*
|
1995-07-28 |
1999-03-02 |
Rutgers, The State University Of New Jersey |
Polymeric drug formulations
|
US7005505B1
(en)
|
1995-08-25 |
2006-02-28 |
Genentech, Inc. |
Variants of vascular endothelial cell growth factor
|
US6020473A
(en)
*
|
1995-08-25 |
2000-02-01 |
Genentech, Inc. |
Nucleic acids encoding variants of vascular endothelial cell growth factor
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
US6100071A
(en)
|
1996-05-07 |
2000-08-08 |
Genentech, Inc. |
Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
|
ATE221049T1
(de)
|
1996-10-15 |
2002-08-15 |
Janssen Pharmaceutica Nv |
Verfahren zur herstellung eines zwischenprodukts in der cisapridsynthese
|
DE69730093T2
(de)
*
|
1996-10-31 |
2006-07-20 |
Takeda Pharmaceutical Co. Ltd. |
Zubereitung mit verzögerter Freisetzung
|
US6171788B1
(en)
|
1997-01-28 |
2001-01-09 |
The Regents Of The University Of California |
Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
|
US6475724B1
(en)
|
1997-01-28 |
2002-11-05 |
The Regents Of The University Of California |
Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
|
US7138511B1
(en)
|
1997-01-28 |
2006-11-21 |
The Regents Of The University Of California |
Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
|
SE512663C2
(sv)
*
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
EP2050762A3
(en)
|
1998-03-10 |
2009-07-08 |
Genentech, Inc. |
Human cornichon-like protein and nucleic acids encoding it
|
US6565874B1
(en)
*
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
AU4390200A
(en)
*
|
1999-02-19 |
2000-09-04 |
Bioserv Ag |
Biodegradable composite material for the production of microcapsules
|
US7078382B1
(en)
|
1999-11-02 |
2006-07-18 |
Genentech, Inc. |
Modulation of eNOS activity and therapeutic uses thereof
|
TW200800298A
(en)
|
2000-01-27 |
2008-01-01 |
Zentaris Ag |
Compressed microparticles for dry injection
|
US7019106B2
(en)
|
2000-08-07 |
2006-03-28 |
Wako Pure Chemical Industries, Ltd. |
Lactic acid polymer and process for producing the same
|
US6824822B2
(en)
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US8470359B2
(en)
|
2000-11-13 |
2013-06-25 |
Qlt Usa, Inc. |
Sustained release polymer
|
CA2451187C
(en)
|
2001-06-22 |
2012-08-14 |
Southern Biosystems, Inc. |
Zero-order prolonged release coaxial implants
|
AR034641A1
(es)
|
2001-06-29 |
2004-03-03 |
Takeda Pharmaceutical |
Composicion de liberacion controlada y metodo para producirla
|
EP1275378B1
(en)
|
2001-07-10 |
2009-04-15 |
Canon Kabushiki Kaisha |
Particulate construct comprising polyhydroxyalkanoate and method for producing it
|
US20040191215A1
(en)
*
|
2003-03-25 |
2004-09-30 |
Michael Froix |
Compositions for induction of a therapeutic response
|
JP2004331750A
(ja)
|
2003-05-02 |
2004-11-25 |
Canon Inc |
ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途
|
DK1675608T3
(da)
|
2003-09-12 |
2007-07-09 |
Wyeth Corp |
Injicerbare faste calciumphosphatstave til indgivelse af osteogene proteiner
|
EA200601904A1
(ru)
|
2004-04-15 |
2007-02-27 |
Алкермес, Инк. |
Система отсроченного высвобождения лекарственного средства на основе полимеров
|
US7456254B2
(en)
*
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
DK2447252T3
(da)
|
2004-05-23 |
2020-03-16 |
Hmi Medical Innovations Llc |
Theramuteinmodulatorer
|
US9345911B2
(en)
*
|
2004-08-04 |
2016-05-24 |
Clinuvel Pharmaceuticals Limited |
Methods of inducing melanogenesis in a subject
|
ES2255426B1
(es)
|
2004-10-19 |
2007-08-16 |
Gp Pharm, S.A. |
Formulacion farmaceutica que comprende microcapsulas de estatinas suspendidas en ester alquilicos de acidos grasos poliinsaturados (pufa).
|
EP1824460B1
(en)
*
|
2004-11-10 |
2014-12-24 |
Tolmar Therapeutics, Inc. |
A stabilized polymeric delivery system
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
US8431110B2
(en)
|
2005-05-23 |
2013-04-30 |
Hmi Medical Innovations, Llc. |
Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
|
KR101502920B1
(ko)
|
2005-06-21 |
2015-03-17 |
조마 (유에스) 엘엘씨 |
IL-1β 결합성 항체 및 그의 단편
|
JP5072057B2
(ja)
*
|
2005-08-22 |
2012-11-14 |
東ソー株式会社 |
微小流路構造体を用いたマイクロカプセルの製造方法
|
KR100722607B1
(ko)
|
2006-05-11 |
2007-05-28 |
주식회사 펩트론 |
분산성 및 주사 투여능이 향상된 서방성 미립구의 제조방법
|
EP2359808B1
(en)
|
2006-08-09 |
2013-05-22 |
Intarcia Therapeutics, Inc |
Osmotic delivery systems and piston assemblies
|
EA016176B1
(ru)
|
2006-12-18 |
2012-02-28 |
Такеда Фармасьютикал Компани Лимитед |
Композиция с замедленным высвобождением и способ её получения
|
WO2008077145A2
(en)
|
2006-12-20 |
2008-06-26 |
Xoma Technology Ltd. |
Treatment of il-1-beta related diseases
|
ES2402172T3
(es)
|
2007-04-23 |
2013-04-29 |
Intarcia Therapeutics, Inc |
Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
|
CA2692171C
(en)
|
2007-06-22 |
2019-10-22 |
Randolph Watnick |
Methods and uses thereof of prosaposin
|
AU2008343085B2
(en)
|
2007-12-20 |
2015-03-12 |
Xoma (Us) Llc |
Methods for the treatment of gout
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
US11395811B2
(en)
|
2009-03-09 |
2022-07-26 |
Pronova Biopharma Norge As |
Compositions comprising a fatty acid oil mixture comprising EPA and DHA in free acid form and a surfactant, and methods and uses thereof
|
WO2010144797A2
(en)
|
2009-06-12 |
2010-12-16 |
Vaccine Technologies, Incorporated |
Influenza vaccines with enhanced immunogenicity and uses thereof
|
EP3323423B1
(en)
|
2009-09-28 |
2020-06-17 |
Intarcia Therapeutics, Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
ES2363964B1
(es)
|
2009-11-20 |
2012-08-22 |
Gp Pharm, S.A. |
Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
|
ES2363965B1
(es)
|
2009-11-20 |
2013-01-24 |
Gp Pharm S.A. |
Cápsulas de principios activos betabloqueantes y ésteres de ácidos grasos poliinsaturados.
|
ES2364011B1
(es)
|
2009-11-20 |
2013-01-24 |
Gp Pharm, S.A. |
Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
|
EP3366695B1
(en)
|
2009-12-17 |
2021-07-07 |
Children's Medical Center Corporation |
Saposin-a derived peptides and uses thereof
|
BR112012015500A2
(pt)
|
2009-12-23 |
2016-05-03 |
Defiante Farmaceutica Sa |
composição de combinação útil para o tratamento de doenças cardiovasculares
|
JP2013525271A
(ja)
|
2010-03-12 |
2013-06-20 |
チルドレンズ メディカル センター コーポレーション |
免疫原およびそのスクリーニング方法
|
ES2383271B1
(es)
|
2010-03-24 |
2013-08-01 |
Lipotec S.A. |
Procedimiento de tratamiento de fibras y/o materiales textiles
|
US9993019B2
(en)
*
|
2010-03-26 |
2018-06-12 |
Philip Morris Usa Inc. |
Method for making particle of a hydrophobic additive and a polysaccharide coating and tobacco products containing particle of a hydrophobic additive and a polysaccharide coating
|
WO2011156594A2
(en)
|
2010-06-09 |
2011-12-15 |
Vaccine Technologies, Incorporated |
Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment
|
ES2385240B1
(es)
|
2010-07-26 |
2013-09-23 |
Gp-Pharm, S.A. |
Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata.
|
WO2012092539A2
(en)
|
2010-12-31 |
2012-07-05 |
Takeda Pharmaceutical Company Limited |
Antibodies to dll4 and uses thereof
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
EP3881836A1
(en)
|
2011-05-11 |
2021-09-22 |
Children's Medical Center Corporation |
Multiple antigen presenting immunogenic composition, and methods and uses thereof
|
US9701731B2
(en)
|
2011-08-19 |
2017-07-11 |
Children's Medical Center Corporation |
VEGF-binding protein for blockade of angiogenesis
|
DE102011114864A1
(de)
*
|
2011-10-05 |
2013-04-11 |
Acino Ag |
Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat
|
WO2013072767A1
(en)
|
2011-11-18 |
2013-05-23 |
Pronova Biopharma Norge As |
Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture
|
CN102511790B
(zh)
*
|
2011-12-05 |
2013-07-24 |
山东好当家海洋发展股份有限公司 |
一种水产蛋白肽微胶囊的制备方法
|
CN102488619B
(zh)
*
|
2011-12-05 |
2014-08-06 |
上海交通大学 |
连续生产艾塞那肽微球的装置及控制微球释放速度的方法
|
CN104144946A
(zh)
|
2011-12-19 |
2014-11-12 |
爱克索马美国有限责任公司 |
治疗痤疮的方法
|
EP4306123A3
(en)
|
2011-12-22 |
2024-04-17 |
Children's Medical Center Corporation |
Saposin-a derived peptides and uses thereof
|
EP3663314A1
(en)
|
2012-01-09 |
2020-06-10 |
The Scripps Research Institute |
Humanized antibodies with ultralong cdr3s
|
EP2802603A4
(en)
|
2012-01-09 |
2015-11-04 |
Scripps Research Inst |
REGIONS DETERMINING ULTRALONGUAL COMPLEMENTARYITY AND USES THEREOF
|
US20150079164A1
(en)
|
2012-04-04 |
2015-03-19 |
Pronova Biopharma Norge As |
Compositions comprising omega-3 fatty acids and vitamin d for acne vulgaris and/or eczema, and methods and uses thereof
|
WO2013150384A1
(en)
|
2012-04-04 |
2013-10-10 |
Pronova Biopharma Norge As |
Compositions comprising omega-3 fatty acids and vitamin d for psoriasis, and methods and uses thereof
|
WO2014124228A1
(en)
|
2013-02-07 |
2014-08-14 |
Children's Medical Center Corporation |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
JP6537980B2
(ja)
|
2013-02-28 |
2019-07-03 |
プロノヴァ・バイオファーマ・ノルゲ・アーエスPronova BioPharma Norge AS |
脂質化合物、トリグリセリドおよび界面活性剤を含む組成物、ならびにその使用方法
|
AU2014290361B2
(en)
|
2013-07-18 |
2019-04-18 |
Taurus Biosciences, Llc |
Humanized antibodies with ultralong complementarity determining regions
|
EP3022224A2
(en)
|
2013-07-18 |
2016-05-25 |
Fabrus, Inc. |
Antibodies with ultralong complementarity determining regions
|
US10286078B2
(en)
|
2013-09-13 |
2019-05-14 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
ES2741308T3
(es)
|
2013-10-15 |
2020-02-10 |
Scripps Research Inst |
Interruptores de células T con receptores de antígenos quiméricos y usos de los mismos
|
CA2927543C
(en)
|
2013-10-15 |
2021-07-20 |
The California Institute For Biomedical Research |
Peptidic chimeric antigen receptor t cell switches and uses thereof
|
US10039809B2
(en)
|
2013-12-18 |
2018-08-07 |
The California Institute For Biomedical Research |
Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
|
EP2977758A1
(en)
|
2014-07-24 |
2016-01-27 |
Université De Nice Sophia Antipolis |
Methods and kits for monitoring membranous nephropathy
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
US10800828B2
(en)
|
2015-03-26 |
2020-10-13 |
The Scripps Research Institute |
Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer
|
EP3283113A4
(en)
|
2015-04-15 |
2018-12-05 |
The California Institute for Biomedical Research |
Optimized pne-based chimeric receptor t cell switches and uses thereof
|
US20190000928A1
(en)
|
2015-06-17 |
2019-01-03 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
KR20240037175A
(ko)
|
2016-05-16 |
2024-03-21 |
인타르시아 세라퓨틱스 인코포레이티드 |
글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
|
CN110267982B
(zh)
|
2016-10-19 |
2024-02-23 |
斯克利普斯研究所 |
具有人源化靶向部分和/或经过优化的嵌合抗原受体相互作用结构域的嵌合抗原受体效应细胞开关以及其用途
|
IL307966A
(en)
|
2017-01-03 |
2023-12-01 |
Intarcia Therapeutics Inc |
Methods involving continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
CN111315365A
(zh)
|
2017-09-26 |
2020-06-19 |
纳奥米有限公司 |
用于通过双乳液技术制备微粒的方法
|
EP4013788A1
(en)
|
2019-08-12 |
2022-06-22 |
Purinomia Biotech, Inc. |
Methods and compositions for promoting and potentiating t-cell mediated immune responses through adcc targeting of cd39 expressing cells
|
CN110585170A
(zh)
*
|
2019-09-17 |
2019-12-20 |
南京赛弗斯医药科技有限公司 |
一种采用3d打印制备的醋酸特利加压素注射用缓释微球及其制备方法
|
JP2022554187A
(ja)
|
2019-10-24 |
2022-12-28 |
ミノトール セラピューティクス インコーポレイテッド |
キメラサイトカイン改変抗体およびその使用方法
|
US20230098350A1
(en)
|
2019-12-31 |
2023-03-30 |
Guangzhou Diqi Pharmaceuticals Co., Ltd . |
Tertiary amine pharmaceutical composition and industrialized batch preparation method thereof
|
AU2022264339A1
(en)
|
2021-04-28 |
2023-11-09 |
Minotaur Therapeutics, Inc. |
Humanized chimeric bovine antibodies and methods of use
|